Updated overview of current biomarkers in head and neck carcinoma.
暂无分享,去创建一个
[1] J. Herman,et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. , 2000, Cancer research.
[2] David Elashoff,et al. Salivary Transcriptome Diagnostics for Oral Cancer Detection , 2004, Clinical Cancer Research.
[3] K. Lee,et al. Body fluid biomarkers for early detection of head and neck squamous cell carcinomas. , 2011, Anticancer research.
[4] B. Fingleton,et al. Matrix metalloproteinases: biologic activity and clinical implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] P. Chu,et al. Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases , 2000, Modern Pathology.
[6] Xiao-Cheng Wu,et al. Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control , 2008, Journal of the National Cancer Institute.
[7] H. Song,et al. Prognostic significance of immunohistochemical expression of p53 gene product in operable breast cancer. , 2006, Cancer research and treatment : official journal of Korean Cancer Association.
[8] Jong-Wook Park,et al. Lung cancer detection by a RT-nested PCR using MAGE A1--6 common primers. , 2004, Lung cancer.
[9] C. Smith,et al. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[10] E. Nkenke,et al. Cytokeratin 17 mRNA expression has potential for diagnostic marker of oral squamous cell carcinoma , 2008, Journal of Cancer Research and Clinical Oncology.
[11] Shu-Chun Lin,et al. Frequent microsatellite alterations of chromosome locus 4q13.1 in oral squamous cell carcinomas. , 2005, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[12] J. Califano,et al. Advances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer. , 2010, Expert opinion on medical diagnostics.
[13] F. Tsai,et al. Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. , 2007, Clinica chimica acta; international journal of clinical chemistry.
[14] John V. Carlis,et al. Quantitative Proteomics Reveals Myosin and Actin as Promising Saliva Biomarkers for Distinguishing Pre-Malignant and Malignant Oral Lesions , 2010, PloS one.
[15] P. Friedl,et al. Collective cell migration in morphogenesis, regeneration and cancer , 2009, Nature Reviews Molecular Cell Biology.
[16] Qing‐Yu He,et al. Comparative proteomic analysis of esophageal squamous cell carcinoma , 2005, Proteomics.
[17] J. Werner,et al. Cytokeratins 6 and 16 are frequently expressed in head and neck squamous cell carcinoma cell lines and fresh biopsies. , 2005, Anticancer research.
[18] F. Abreo,et al. Correlation of p53 and the proto-oncogene eIF4E in larynx cancers: prognostic implications. , 2000, Cancer research.
[19] H. Chang,et al. Expression of MAGE A 1-6 mRNA in sputa of head and neck cancer patients--a preliminary report. , 2006, Anticancer research.
[20] Dong Eun Kim,et al. Detection of MAGE and SSX Gene Expressions by RT-nested PCR Using Common Primers in Head and Neck Cancer , 2008, Clinical and experimental otorhinolaryngology.
[21] P. Bradley,et al. New molecular diagnostic methods in head and neck cancer , 2005, Head & neck.
[22] F. Gilliland,et al. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. , 2002, Cancer research.
[23] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[24] Long-Bang Chen,et al. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma. , 2009, Lung cancer.
[25] J. Manola,et al. TP53 mutations and survival in squamous-cell carcinoma of the head and neck. , 2007, The New England journal of medicine.
[26] A. Simpson,et al. Detection of oral and oropharyngeal cancer by microsatellite analysis in mouth washes and lesion brushings. , 2000, Oral oncology.
[27] V. Grégoire,et al. PET imaging biomarkers in head and neck cancer , 2015, European Journal of Nuclear Medicine and Molecular Imaging.
[28] K. Krapfenbauer,et al. Identification of differentially expressed, tumor‐associated proteins in oral squamous cell carcinoma by proteomic analysis , 2006, Electrophoresis.
[29] P. Parsons,et al. Molecular introduction to head and neck cancer (HNSCC) carcinogenesis. , 2004, British journal of plastic surgery.
[30] A. Nadal,et al. Carcinoma of the head and neck in the HPV era. , 2011, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.
[31] S. Chakraborty,et al. Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma , 2008, BMC Cancer.
[32] E. Prakash,et al. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway. , 2008, Carcinogenesis.
[33] S. Prime,et al. Spindle assembly checkpoint and centrosome abnormalities in oral cancer. , 2007, Cancer letters.
[34] P. Roche,et al. Identification of NY‐ESO‐1, MAGE‐1, and MAGE‐3 in head and neck squamous cell carcinoma , 2003, Head & neck.
[35] R. Kannagi,et al. Expression of CC-chemokine receptor 7 (CCR7) and CXC-chemokine receptor 4 (CXCR4) in head and neck squamous cell carcinoma. , 2010, Auris, nasus, larynx.
[36] E. Sabo,et al. Cytokeratin-17 as a Potential Marker for Squamous Cell Carcinoma of the Larynx , 2004, The Annals of otology, rhinology, and laryngology.
[37] S. Somiari,et al. Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer. , 2006, Cancer letters.
[38] A. Kaufmann,et al. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro. , 2015, International journal of oncology.
[39] E. Sabo,et al. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens in serous ovarian neoplasms. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[40] David Hardisson,et al. Molecular pathogenesis of head and neck squamous cell carcinoma , 2003, European Archives of Oto-Rhino-Laryngology.
[41] Shan-zhen Sun,et al. Expression of stromal CD34 and α-smooth muscle actin in oral invasive cancer , 2006 .
[42] Benjamin D. L. Li,et al. Detection of the proto-oncogene eIF4E in surgical margins may predict recurrence in head and neck cancer , 1997, Oncogene.
[43] Jens Overgaard,et al. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] D. Speiser,et al. Pattern and clinical significance of cancer‐testis gene expression in head and neck squamous cell carcinoma , 2011, International journal of cancer.
[45] K. Fukasawa,et al. Loss of p53 and centrosome hyperamplification , 2002, Oncogene.
[46] J. Graff,et al. eIF-4E expression and its role in malignancies and metastases , 2004, Oncogene.
[47] Tim Crook,et al. The p53 network in head and neck cancer. , 2003, Oral oncology.
[48] A. Juretić,et al. Prognostic value of MAGE‐A and NY‐ESO‐1 expression in pharyngeal cancer , 2010, Head & neck.
[49] M. Alonso-Guervós,et al. Analysis of Microsatellite Instability in Laryngeal Squamous Cell Carcinoma , 2012 .
[50] C. Romanini,et al. Increased serum 72 KDa metalloproteinase in serous ovarian tumors: comparison with CA 125. , 1996, Anticancer research.
[51] A. Harris,et al. Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression , 1999, British Journal of Cancer.
[52] C. R. Leemans,et al. Protein biomarker discovery for head and neck cancer. , 2010, Journal of proteomics.
[53] J. Wiltfang,et al. Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy. , 2005, International journal of oncology.
[54] N. Park,et al. Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer Detection , 2009, Clinical Cancer Research.
[55] G. Cheon,et al. Usefulness of Integrated PET/MRI in Head and Neck Cancer: A Preliminary Study , 2013, Nuclear Medicine and Molecular Imaging.
[56] L. Villa,et al. Impact of HPV infection on the development of head and neck cancer , 2013, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[57] M. Correnti,et al. Human papillomavirus detection in head and neck squamous cell carcinoma , 2014, Ecancermedicalscience.
[58] A. Simpson,et al. MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. , 2007, Cancer research.
[59] A. Heidarzadeh,et al. p53 overexpression impacts on the prognosis of laryngeal squamous cell carcinomas. , 2011, Asian Pacific journal of cancer prevention : APJCP.
[60] De-Pei Liu,et al. MicroRNAs: key participants in gene regulatory networks. , 2003, Current opinion in chemical biology.
[61] G. Ling,et al. Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma , 2004, Cancer.
[62] G. Snow,et al. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer , 2002, The Journal of pathology.
[63] M. Louka,et al. Evaluation of matrix metalloproteinase‐2 in lung cancer , 2014, Proteomics. Clinical applications.
[64] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[65] W. A. Yeudall,et al. Down-regulation of CXCL5 inhibits squamous carcinogenesis. , 2006, Cancer research.
[66] K. Odunsi,et al. Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy. , 2010, Future oncology.
[67] Y. Zeng,et al. Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome , 2005, Journal of Translational Medicine.
[68] T. Godfrey,et al. Expression Pattern of Chemokine Receptor 6 (CCR6) and CCR7 in Squamous Cell Carcinoma of the Head and Neck Identifies a Novel Metastatic Phenotype , 2004, Cancer Research.
[69] C. Meschonat,et al. A Prospective Trial on Initiation Factor 4E (eIF4E) Overexpression and Cancer Recurrence in Node-Negative Breast Cancer , 2008, Annals of Surgical Oncology.
[70] E. Ioachim,et al. Biomarkers of head and neck cancer, tools or a gordian knot? , 2015, International journal of clinical and experimental medicine.
[71] Yuriy Gusev,et al. Real-time expression profiling of microRNA precursors in human cancer cell lines , 2005, Nucleic acids research.
[72] J. M. Thomson,et al. MicroRNA expression profiles in head and neck cancer cell lines. , 2007, Biochemical and biophysical research communications.
[73] King-Jen Chang,et al. Expression of eukaryotic initiation factor 4E in gastric adenocarcinoma and its association with clinical outcome , 2004, Journal of surgical oncology.
[74] W. Pepiński,et al. Evaluation of tumor microsatellite instability in laryngeal cancer using five quasimonomorphic mononucleotide repeats and pentaplex PCR. , 2008, Advances in medical sciences.
[75] K. Fukasawa,et al. Centrosome Hyperamplification in Head and Neck Squamous Cell Carcinoma: A Potential Phenotypic Marker of Tumor Aggressiveness , 2000, The Laryngoscope.
[76] O. Kent,et al. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes , 2006, Oncogene.
[77] H. Quon,et al. FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma. , 2012, Imaging in medicine.
[78] Faina Linkov,et al. Early Detection of Head and Neck Cancer: Development of a Novel Screening Tool Using Multiplexed Immunobead-Based Biomarker Profiling , 2007, Cancer Epidemiology Biomarkers & Prevention.
[79] Victor G Prieto,et al. Metastatic basal cell carcinoma exhibits reduced actin expression , 2008, Modern Pathology.
[80] N. Dalay,et al. Assessment of microsatellite instability in head and neck cancer using consensus markers , 2010, Molecular Biology Reports.
[81] U. Moll,et al. Mr 92,000 Type IV Collagenase Is Increased in Plasma of Patients with Colon Cancer and Breast Cancer , 1993 .
[82] J. Werner,et al. Tumor marker potential of serum matrix metalloproteinases in patients with head and neck cancer. , 2002, Anticancer research.
[83] William Lee,et al. Unraveling the molecular genetics of head and neck cancer through genome-wide approaches , 2014, Genes & diseases.
[84] A. Zaravinos. An updated overview of HPV-associated head and neck carcinomas , 2014, Oncotarget.
[85] Y. Maehara,et al. The instability within: problems in current analyses of microsatellite instability. , 2001, Mutation research.
[86] D. Sidransky,et al. Head and neck cancer. , 2001, The New England journal of medicine.
[87] D. Speiser,et al. MAGE-A3 and MAGE-A4 specific CD4+ T cells in head and neck cancer patients: detection of naturally acquired responses and identification of new epitopes , 2010, Cancer Immunology, Immunotherapy.
[88] E. Nkenke,et al. MAGE-A as a novel approach in the diagnostic accuracy of oral squamous cell cancer: a case report , 2009, Head & neck oncology.
[89] L. Mariani,et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[90] Keith D Robertson,et al. DNA methyltransferases, DNA damage repair, and cancer. , 2013, Advances in experimental medicine and biology.
[91] Hsueh-Wei Chang,et al. Matrix metalloproteinases (MMP) 1 and MMP10 but not MMP12 are potential oral cancer markers , 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[92] Andrew Feber,et al. MicroRNA expression profiles of esophageal cancer. , 2008, The Journal of thoracic and cardiovascular surgery.
[93] Wei Shi,et al. Comprehensive MicroRNA Profiling for Head and Neck Squamous Cell Carcinomas , 2010, Clinical Cancer Research.
[94] Cun-Yu Wang,et al. CXCL12/SDF-1α Activates NF-κB and Promotes Oral Cancer Invasion through the Carma3/Bcl10/Malt1 Complex , 2009, International Journal of Oral Science.
[95] B. Cakmakoglu,et al. MCP-1 and CCR2 gene variants in oral squamous cell carcinoma. , 2012, Oral diseases.
[96] Christoph Lahtz,et al. Epigenetic changes of DNA repair genes in cancer. , 2011, Journal of molecular cell biology.
[97] H. Goike,et al. Clinical utility of cytokeratins as tumor markers. , 2004, Clinical biochemistry.
[98] E. Srivatsan,et al. Suppression of interleukin 6 and 8 production in head and neck cancer cells with curcumin via inhibition of Ikappa beta kinase. , 2009, Archives of otolaryngology--head & neck surgery.
[99] Ratnesh K Singh,et al. Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population , 2006, Journal of Clinical Pathology.
[100] E. Vairaktaris,et al. Expression of cytokeratin 17 mRNA in oral squamous cell carcinoma cells obtained by brush biopsy: preliminary results. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[101] N. Park,et al. Genomic Targets in Saliva , 2007, Annals of the New York Academy of Sciences.
[102] J. Wiltfang,et al. Expression of melanoma-associated antigens in oral squamous cell carcinoma. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[103] C. Chung,et al. Emerging biomarkers in head and neck cancer in the era of genomics , 2015, Nature Reviews Clinical Oncology.
[104] P. Slootweg,et al. Gain-of-function mutations in the tumor suppressor gene p53. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[105] P. Pandolfi,et al. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis , 2004, Nature Medicine.
[106] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[107] N. Sonenberg,et al. eIF4E – from translation to transformation , 2004, Oncogene.
[108] A. Eisbruch,et al. Biomarkers in advanced larynx cancer , 2014, The Laryngoscope.
[109] B. Perez-Ordonez,et al. Molecular biology of squamous cell carcinoma of the head and neck , 2006, Journal of Clinical Pathology.
[110] J. R. de los Toyos,et al. The usefulness of new serum tumor markers in head and neck squamous cell carcinoma , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[111] Xiao-jun Zhou,et al. Expression of CD34, α-Smooth Muscle Actin and Transforming Growth Factor-β1 in Squamous Intraepithelial Lesions and Squamous Cell Carcinoma of the Cervix , 2009 .
[112] R. Moll. Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors. , 1998, Sub-cellular biochemistry.
[113] Sung Won Kim,et al. Clinical significance of melanoma‐associated antigen A1–6 expression in sputum of patients with squamous cell carcinoma of the larynx and hypopharynx , 2016, Head & neck.
[114] G. Sauter,et al. Prognostic relevance of MAGE‐A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: A tissue microarray study , 2002, International journal of cancer.
[115] D. Crowe,et al. Role of microRNA-138 as a potential tumor suppressor in head and neck squamous cell carcinoma. , 2013, International review of cell and molecular biology.
[116] E. D. Bal de Kier Joffé,et al. Circulating 92‐kilodalton matrix metalloproteinase (MMP‐9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma , 2002, Cancer.
[117] W. Hong,et al. Focus on head and neck cancer. , 2004, Cancer cell.
[118] L. Zhang,et al. Overexpression of cytokeratin 17 protein in oral squamous cell carcinoma in vitro and in vivo. , 2009, Oral diseases.
[119] Jonathan R. Clark,et al. BASIC SCIENCE REVIEW , 2006 .
[120] S. Faivre,et al. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial. , 2013, The Lancet. Oncology.